We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




AI Tool Automates Validation of Laboratory Software Configuration Changes

By LabMedica International staff writers
Posted on 20 May 2026

Regulated laboratories face heavy documentation and requalification demands when software configurations change, slowing improvements and discouraging beneficial updates. More...

A new capability now automates planning, execution, and audit-ready documentation for configuration changes in regulated laboratory systems.

Labbit (Vancouver, BC, Canada) has introduced the Validation Assistant as the latest addition to its change management lifecycle for regulated laboratories. Building on the Configuration Assistant unveiled in 2025, the artificial intelligence (AI)-powered feature targets the most time-consuming elements of revalidation. The capability is designed to help laboratories manage system changes more efficiently without sacrificing control or system validation status.

When a new Labbit configuration is created, the Validation Assistant detects what has changed and automatically generates the corresponding test plan, test scenarios, and scripts from the configuration version. It then executes the qualification run and assembles an audit-ready documentation package. The package includes the configuration specification, test plan, execution log, and a summary report to support traceability and minimize manual documentation effort.

The new capability streamlines qualification of configuration updates before deployment to production by generating and executing validation assets directly from the system configuration. It addresses a longstanding bottleneck that has required extensive manual revalidation activities prior to changes being promoted. Labbit will showcase the Validation Assistant at booth 518 during the Bio-IT World Conference & Expo in Boston from May 19 to 21, with live demonstrations of automated documentation workflows for configuration changes.

“Validating a configured piece of software in a regulated lab can be as much work as configuration itself – sometimes even more. Labs have spent years managing configuration risk by limiting change, because every update can create a significant documentation and requalification burden. With the Validation Assistant, we’re applying AI to a very specific operational problem: generating and executing validation assets directly from the system configuration itself,” said Peter Smith, CEO of Labbit.

“In a market where there’s a lot of broad discussion around AI, we think this is a good example of practical AI that addresses a real bottleneck in laboratory operations,” added Smith.

Related Links
Labbit


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Blood Biomarker May Track Bone Metastases in Medullary Thyroid Cancer

Medullary thyroid cancer (MTC) is a rare malignancy that often progresses silently, frequently going undetected until it reaches advanced stages. By the time it spreads to bone, it can produce unusual... Read more

Molecular Diagnostics

view channel
Image: In the Fetal Extracellular Vesicle Monitoring of Oxygenation (FEMOx) project several of the Wyss Institute’s Technology Platforms and faculty labs join forces. Leveraging and integrating multiple of the Wyss Institute’s technological innovations and advanced analytical capabilities they aim develop a test that can rapidly and accurately detect fetal oxygen deprivation by detecting specific miRNA signatures in extracellular vesicles (EVs) that circulate in maternal blood. (Iimage Credit: Wyss Institute at Harvard University)

Project to Develop Maternal Blood Test for Rapid Fetal Oxygen Deprivation Detection

Intrapartum fetal hypoxia remains difficult to assess with existing monitoring, leaving clinicians to make time-critical decisions with incomplete data. Limited detection and interpretation can contribute... Read more

Microbiology

view channel
Image: The current BDBV outbreak in the DRC underscores response challenges for rare, severe infections (Image Credit: 123RF)

Research Strengthens Bundibugyo Virus Outbreak Readiness with Faster Diagnostics

Bundibugyo virus (BDBV), a species of ebolavirus, causes severe hemorrhagic disease and can be difficult to diagnose rapidly during outbreaks. Recent regulatory changes have further complicated swift deployment... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.